The role of CD44 in the pathophysiology of chronic lymphocytic leukemia

CD44 interactions with hyaluronan (HA) play a key role in various malignancies, supporting tumor cell migration, adhesion, and survival. In contrast to solid tumors, the expression of CD44 standard and variant forms and their functional interplay with hyaluronan is less understood in hematological m...

Full description

Bibliographic Details
Main Authors: Julia Christine Gutjahr, Richard eGreil, Tanja Nicole Hartmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00177/full
_version_ 1818127818231382016
author Julia Christine Gutjahr
Julia Christine Gutjahr
Richard eGreil
Richard eGreil
Tanja Nicole Hartmann
Tanja Nicole Hartmann
author_facet Julia Christine Gutjahr
Julia Christine Gutjahr
Richard eGreil
Richard eGreil
Tanja Nicole Hartmann
Tanja Nicole Hartmann
author_sort Julia Christine Gutjahr
collection DOAJ
description CD44 interactions with hyaluronan (HA) play a key role in various malignancies, supporting tumor cell migration, adhesion, and survival. In contrast to solid tumors, the expression of CD44 standard and variant forms and their functional interplay with hyaluronan is less understood in hematological malignancies. Chronic lymphocytic leukemia (CLL) is a highly abundant B cell malignancy with a well coordinated balance between cell cycle-arrest and proliferation of tumor subpopulations. The long-term survival and proliferation of CLL cells requires their dynamic interactions with stromal and immune cells in lymphoid organs. Interactions of HA with CD44 and HA-mediated motility receptor (RHAMM) contribute to CLL cell localization, and hence CLL pathophysiology, by shaping homing, interstitial migration, and adhesion of the tumor cells. CD44 can complex with key prognostic factors of CLL, particularly CD38 and CD49d, bridging the gap between prognosis and cellular function. Here, we review the current evidence for the individual and associated contributions of CD44 to CLL pathophysiology, the dynamic functional regulation of CD44 upon CLL cell activation, and possible therapeutic strategies targeting CD44 in CLL.
first_indexed 2024-12-11T07:23:24Z
format Article
id doaj.art-67b88bde08fa401b8d9a316a156ed606
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T07:23:24Z
publishDate 2015-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-67b88bde08fa401b8d9a316a156ed6062022-12-22T01:16:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242015-04-01610.3389/fimmu.2015.00177136284The role of CD44 in the pathophysiology of chronic lymphocytic leukemiaJulia Christine Gutjahr0Julia Christine Gutjahr1Richard eGreil2Richard eGreil3Tanja Nicole Hartmann4Tanja Nicole Hartmann5Paracelsus Medical UniversitySalzburg Cancer Research InstituteParacelsus Medical UniversitySalzburg Cancer Research InstituteParacelsus Medical UniversitySalzburg Cancer Research InstituteCD44 interactions with hyaluronan (HA) play a key role in various malignancies, supporting tumor cell migration, adhesion, and survival. In contrast to solid tumors, the expression of CD44 standard and variant forms and their functional interplay with hyaluronan is less understood in hematological malignancies. Chronic lymphocytic leukemia (CLL) is a highly abundant B cell malignancy with a well coordinated balance between cell cycle-arrest and proliferation of tumor subpopulations. The long-term survival and proliferation of CLL cells requires their dynamic interactions with stromal and immune cells in lymphoid organs. Interactions of HA with CD44 and HA-mediated motility receptor (RHAMM) contribute to CLL cell localization, and hence CLL pathophysiology, by shaping homing, interstitial migration, and adhesion of the tumor cells. CD44 can complex with key prognostic factors of CLL, particularly CD38 and CD49d, bridging the gap between prognosis and cellular function. Here, we review the current evidence for the individual and associated contributions of CD44 to CLL pathophysiology, the dynamic functional regulation of CD44 upon CLL cell activation, and possible therapeutic strategies targeting CD44 in CLL.http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00177/fullmicroenvironmentHomingCD44VLA-4chronic lymphocytic leukemiahyaluronan
spellingShingle Julia Christine Gutjahr
Julia Christine Gutjahr
Richard eGreil
Richard eGreil
Tanja Nicole Hartmann
Tanja Nicole Hartmann
The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
Frontiers in Immunology
microenvironment
Homing
CD44
VLA-4
chronic lymphocytic leukemia
hyaluronan
title The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
title_full The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
title_fullStr The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
title_full_unstemmed The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
title_short The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
title_sort role of cd44 in the pathophysiology of chronic lymphocytic leukemia
topic microenvironment
Homing
CD44
VLA-4
chronic lymphocytic leukemia
hyaluronan
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00177/full
work_keys_str_mv AT juliachristinegutjahr theroleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT juliachristinegutjahr theroleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT richardegreil theroleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT richardegreil theroleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT tanjanicolehartmann theroleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT tanjanicolehartmann theroleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT juliachristinegutjahr roleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT juliachristinegutjahr roleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT richardegreil roleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT richardegreil roleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT tanjanicolehartmann roleofcd44inthepathophysiologyofchroniclymphocyticleukemia
AT tanjanicolehartmann roleofcd44inthepathophysiologyofchroniclymphocyticleukemia